Literature DB >> 9500955

Abnormal expression of cell recognition molecules in schizophrenia.

M P Vawter1, H E Cannon-Spoor, J J Hemperly, T M Hyde, D M VanderPutten, J E Kleinman, W J Freed.   

Abstract

Schizophrenia is a neuropsychiatric disorder of unknown etiology associated with subtle changes in brain morphology. The cell recognition molecules (CRMs) neural cell adhesion molecule (N-CAM) and L1 are involved in morphoregulatory events and numerous neurodevelopmental processes. We found a selective increase of 105- to 115-kDa N-CAM in the hippocampus and prefrontal cortex of patients with schizophrenia while other N-CAM isoforms and L1 proteins were not altered. There was also evidence for an abnormality in CRM expression in schizophrenic patients: concentrations of 200-kDa L1 were strongly correlated with expression of N-CAM isoforms and cleaved L1 proteins in controls, whereas these correlations were absent in patients with schizophrenia. The increase of the 105- to 115-kDa N-CAM isoform in the brains of patients with schizophrenia confirms previous cerebrospinal fluid findings. Increased N-CAM in schizophrenia may result from structural brain abnormalities, from glial processing of N-CAM, or from an aberration in the regulation of N-CAM expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500955     DOI: 10.1006/exnr.1997.6721

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

1.  L1 cell adhesion molecule found in human CSF varies as a function of age.

Authors:  Mary L Nock; Mary Ann O'riordan; Ningfeng Tang; Cynthia F Bearer
Journal:  Exp Neurol       Date:  2006-07-21       Impact factor: 5.330

2.  Developmental regulation of neural cell adhesion molecule in human prefrontal cortex.

Authors:  E T Cox; L H Brennaman; K L Gable; R M Hamer; L A Glantz; A-S Lamantia; J A Lieberman; J H Gilmore; P F Maness; L F Jarskog
Journal:  Neuroscience       Date:  2009-04-22       Impact factor: 3.590

3.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

Review 4.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

5.  Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia.

Authors:  A S Gibbons; E A Thomas; B Dean
Journal:  Schizophr Res       Date:  2009-05-02       Impact factor: 4.939

6.  Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

Authors:  Shaheen Emmanuel Lakhan
Journal:  Diagn Pathol       Date:  2006-07-17       Impact factor: 2.644

Review 7.  Intercellular protein-protein interactions at synapses.

Authors:  Xiaofei Yang; Dongmei Hou; Wei Jiang; Chen Zhang
Journal:  Protein Cell       Date:  2014-04-23       Impact factor: 14.870

8.  Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM.

Authors:  F Piras; M Schiff; C Chiapponi; P Bossù; M Mühlenhoff; C Caltagirone; R Gerardy-Schahn; H Hildebrandt; G Spalletta
Journal:  Transl Psychiatry       Date:  2015-10-13       Impact factor: 6.222

9.  Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.

Authors:  J F Enwright Iii; Z Huo; D Arion; J P Corradi; G Tseng; D A Lewis
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.